SCHEMBL296220

SCHEMBL296220

CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.63
CA1 P00915 4/20 0.63
MAPK1 P28482 2/20 0.53
ATM Q13315 2/20 0.44
GAA P10253 1/20 0.44
XBP1 P17861 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TSHR P16473 3/20 0.40
CYP3A4 P08684 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
USP2 O75604 1/20 0.37
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14640944 1.00 CA2 (0.63) CA2CA1MAPK1ATMGAA
SCHEMBL15196275 0.92 CA2 (0.54) CA2CA1MAPK1ATMGAA
SCHEMBL247218 0.91 CA2 (0.58) CA2CA1MAPK1ATMGAA
SCHEMBL15062355 0.90 CA2 (0.50) CA2CA1MAPK1ATMGAA
SCHEMBL4442929 0.90 CA2 (0.53) CA2CA1MAPK1ATMGAA
SCHEMBL4452768 0.90 CA2 (0.53) CA2CA1MAPK1ATMGAA
SCHEMBL4445495 0.90 CA2 (0.53) CA2CA1MAPK1ATMGAA
SCHEMBL15196262 0.89 CA2 (0.51) CA2CA1MAPK1ATMGAA
SCHEMBL9960580 0.89 CA2 (0.63) CA2CA1MAPK1ATMGAA
SCHEMBL14337402 0.89 CA2 (0.63) CA2CA1MAPK1ATMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 995 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075332-A Composition, preparation method thereof and sun-screening composition 2026-05-26 CN claimed
CN-120131458-A Biological molecular film composition, skin external preparation, and preparation method and application thereof 上海司锘亿生物科技有限公司 2025-06-13 CN claimed
CN-119868168-A Bicontinuous phase cleansing cream composition and preparation method thereof 杭州舒彩网络科技有限公司 2025-04-25 CN claimed
CN-119700586-A Oil phase inclusion, oil phase inclusion preparation method and water-based skin care composition 深圳市护家科技有限公司 2025-03-28 CN claimed
CN-119656075-A Composition for relieving, repairing, tightening and anti-wrinkle as well as preparation method and application thereof 广州优理氏生物科技有限公司 2025-03-21 CN claimed
CN-115023215-B Formulation providing long-lasting fragrance performance 弗门尼舍有限公司 2025-03-21 CN claimed
CN-118948631-B Oil-in-water cleansing composition 深圳市护家科技有限公司 2025-02-14 CN claimed
CN-119015394-A Sulfur-containing compound preparation, and preparation method and application thereof 上海优斐斯生物科技有限公司 2024-11-26 CN claimed
CN-118948631-A Oil-in-water cleansing composition 深圳市护家科技有限公司 2024-11-15 CN claimed
CN-116211742-B Microemulsion and preparation method thereof 上海林清轩生物科技有限公司 2024-11-15 CN claimed
US-6703436-B2 ESPECIALLY A ESTERS FORMED BY REACTING NEOPENTYL GLYCOL WITH A MIXTURE OF 2-ETHYLHEXANOIC ACID AND BENZOIC ACID; IMPROVED TENSILE STRENGTH, ELONGATION, STATIC HEAT RESISTANCE, AND VISCOSITY STABILITY LG CHEM, LTD. (KR) 2004-03-09 US claimed
US-20030118532-A1 Water-in-oil emulsified make-up composition THE PROCTER & GAMBLE COMPANY 2003-06-26 US claimed
US-20030061969-A1 Neopentylglycol ester based plasticizer composition for polyvinyl chloride resin and method of process thereof LG CHEM, LTD. (KR) 2003-04-03 US claimed
EP-1290077-A1 Neopentylglycol ester based plasticizer composition for polyvinyl chloride resin and method of process thereof LG Chem, Ltd. (KR) 2003-03-12 EP claimed
WO-2002068522-A1 NEOPENTYLGLYCOL ESTER BASED PLASTICIZER COMPOSITION FOR POLYVINYL CHLORIDE RESIN AND METHOD OF PROCESS THEREOF LG CHEM, LTD. (KR) 2002-09-06 WO claimed
WO-2001091704-A1 WATER-IN-OIL EMULSIFIED MAKE-UP COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2001-12-06 WO claimed
US-5516506-A LOTIONS WITH GLYCERINE, MAGNESIUM ALUMINUM SILICATE, XANTHAN GUM, ISOSTEARIC ACID, SILICONES, OCTYL METHOXY CINNAMATE AND EMOLLIENTS AND ESTER COMPOUNDS BERNEL CHEMICAL CO. (US) 1996-05-14 US claimed
US-5476643-A Neopentyl glycol diesters as wetting agents BERNEL CHEMICAL CO. (US) 1995-12-19 US claimed
US-4637930-A VASODILATION, HYPOTENSIVES YAMANOUCHI PHARMACEUTICAL CO, LTD. (JP) 1987-01-20 US claimed
US-4243657-A ALCOHOLS, ESTERS, POLYDIMETHYLSILOXANE KAO SOAP CO., LTD. (JP) 1981-01-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030118532-A1 Water-in-oil emulsified make-up composition LIPA, LRBA, AQP1 CA2 4710/4885CA1 4298/4885MAPK1 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.